Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29185815 | 1.00 | MEN1 (0.38) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL29185855 | 0.82 | CYP3A4 (0.44) | MEN1KMT2ACYP3A4ALOX15ALDH1A1 | |
| SCHEMBL29185823 | 0.74 | ACE2 (0.33) | — | |
| SCHEMBL10696498 | 0.74 | MEN1 (0.40) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL29185883 | 0.72 | KCNH3 (0.36) | — | |
| SCHEMBL16357610 | 0.72 | ALDH1A1 (0.50) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL94185 | 0.72 | MEN1 (0.39) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL14867325 | 0.72 | MEN1 (0.47) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL464975 | 0.72 | MEN1 (0.39) | MEN1KMT2ACYP3A4ALOX15KDM4E | |
| SCHEMBL14867327 | 0.72 | MEN1 (0.47) | MEN1KMT2ACYP3A4ALOX15KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240294470-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2024-09-05 | — | — | US | disclosed |
| CN-117500783-A | Perfume compounds | 奇华顿股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2022261956-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2022-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294470-A1 | FRAGRANCE COMPOUNDS | FASN, FAAH2, FADS2 | MEN1 4388/4885KMT2A 2060/4885CYP3A4 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.